The BriefBrief · Intelligence, not news.
Download on the App Store Get it on Google Play

Daraxonrasib trial shows tumor shrinkage

Researchers conducting early medical trials found that daily daraxonrasib combined with chemotherapy stopped tumors growing in almost all 61 participants with recently diagnosed advanced pancreatic cancer that had spread. Cancer became undetectable on scans in one in 12 patients; a separate account said the combination produced tumor responses in 60.7%, including five patients with no detectable tumors. Doctors said durability is unclear and it is not a cure.

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.
Europäische Ukraine-Unterstützer halten in Berlin zusammen
Friedrich Merz Nov 19, 2026 at 8:50 PM ET
Laurel man convicted in Temple Hills triple killing
Murder Nov 19, 2026 at 8:21 PM ET
U.S. Marshals Join Search for Wheaton Stabbing Suspect
Wheaton Nov 19, 2026 at 8:21 PM ET
Polls Give Feijóo Edge After Spain TV Debate
Spain Nov 19, 2026 at 8:06 PM ET

Page 137 of 23108

Same format. Every time.

Continue reading — sign in or create a free account with